How much does the global biopharmaceutical industry spends a year on R&D?
How much does it cost to bring a drug to market?
What are the odds of success of a lead compound approved for human usage?
What are the top performing therapeutic areas?
What are the fastest-growing therapeutic areas?
How much is the pot of gold at the end of the rainbow worth?
>> To find out more about these key facts and figures, download our free ebook now
Join the likes of Bayer Healthcare, Eisai, GlaxoSmithKline, Novartis, RaQualia Pharma, Roche, A*STAR, Chugai Pharmabody Research, Sanofi-Pasteur, Sanofi-Aventis, Ontario Institute for Cancer Research, Mayo Clinic and Mount Sinai School of Medicine, at the upcoming Drug Discovery World Asia 2013 and learn how to re-formulate your R&D strategies for increased speed to market and profitability.
For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D